Please use this identifier to cite or link to this item:
|Title:||Clostridium histolyticum collagenase in the treatment of Dupuytren's contracture|
|Authors:||Azzopardi, Ernest A.|
Boyce, Dean E.
|Keywords:||Dupuytren's contracture -- Treatment|
Dupuytren's contracture -- Surgery -- Complications
Clostridium histolyticum -- Enzymology
Collagenases -- Therapeutic use
|Publisher:||Mark Allen Publishing|
|Citation:||Azzopardi, E. A., & Boyce, D. E. (2012). Clostridium histolyticum collagenase in the treatment of Dupuytren's contracture. British Journal of Hospital Medicine, 73(8), 432-436.|
|Abstract:||Dupuytren’s disease is a common, costly and recurrent health issue. This review compares Clostridum histolyticumcollagenase with current operative treatments. Collagenase management is an effective non-surgical alternative associated with lower risks of serious adverse events, but higher incidence of non-serious adverse events.|
|Appears in Collections:||Scholarly Works - FacM&SAna|
Files in This Item:
|166.31 kB||Adobe PDF||View/Open Request a copy|
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.